✦ LIBER ✦

Serum levels of soluble Fas/APO-1 receptor are increased in systemic sclerosis

✍ Scribed by T. Wetzig; J. B. Petri; M. Mittag; U.-F. Haustein

Publisher: Springer-Verlag
Year: 1998
Tongue: English
Weight: 66 KB
Volume: 290
Category: Article
ISSN: 0340-3696
DOI: 10.1007/s004030050288

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased serum levels of soluble CD95 (

Increased serum levels of soluble CD95 (APO-1/Fas) in relapsing-remitting multiple sclerosis

✍ Dr. Frauke Zipp; Michael Weller; Peter A. Calabresi; Joseph A. Frank; Craig N. B 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 633 KB

Nucleus-driven multiple large-scale deletions of the human mitochondrial genome: a new autosomal dominant disease. Am J Hum Genet 1990; 47:904-914 10. Moraes CT, Ciacci F, Bonilla E, et al. Two novel pathogenetic mitochondrial DNA mutations affecting organelle number and protein synthesis. Is the tR

Serum CCL23 levels are increased in pati

Serum CCL23 levels are increased in patients with systemic sclerosis

✍ Koichi Yanaba; Ayumi Yoshizaki; Eiji Muroi; Fumihide Ogawa; Yoshihide Asano; Tak 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 562 KB

Serum soluble Fas/APO-1 is increased in

Serum soluble Fas/APO-1 is increased in patients with primary Sjögren's syndrome

✍ T. Fujihara; T. Takeuchi; K. Tsubota; N. Kayagaki; H. Yagita; K. Okumura; T. Abe 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 462 KB

The levels of serum-soluble Fas in patie

The levels of serum-soluble Fas in patients with rheumatoid arthritis and systemic sclerosis

✍ Aşkın Ateş; Gülay Kinikli; Murat Turgay; Murat Duman 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 190 KB

Lack of correlation between serum solubl

Lack of correlation between serum soluble fas/APO-1 levels and autoimmune disease

✍ Niti Goel; E. S. T. William Clair; Judith A. Fleming; Dawn T. Ulrich; David H. L 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

Levels of soluble fas/APO-1 /CD95 in sys

Levels of soluble fas/APO-1 /CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis

✍ Eckart Knipping; Peter H. Krammer; Karen B. Onel; Thomas J. A. Lehman; Eduardo M 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 2 views

To quantify soluble Fas/APO-1 (sFas/ APO-1) protein in the serum of patients with systemic lupus erythematosus (SLE) and juvenile rheumatoid arthritis (JRA). Methods. Soluble Fas/APO-1 was quantified using a sandwich enzyme-linked immunosorbent assay. Disease activity in SLE patients was assessed b